Introduction
We examined an unusual case where a radioactive plaque was placed on top of a functioning filtering bleb during treatment of a subjacent ciliary body melanoma. While there was risk of damage to the conjunctiva, this technique offered a chance to spare the filtering mechanism.
Methods

Fig. 1 -(A)
Slit-lamp photograph reveals the functioning filtering bleb partially overhanging the cornea. (B) In downgaze, a small area of extrascleral tumor extension is seen beneath the conjunctiva (black arrow). Bottom: High-frequency ultrasound imaging (35 MHz) longitudinal section (C) and transverse section (D) reveal a dome-shaped, 2.0-mm height, moderately reflective ciliary body melanoma, with extrascleral extension (white arrows).
Informed consent involved a detailed discussion of the risks and relative benefits of observation, radiation (plaque and proton beam), excisional surgery, and enucleation. We further discussed that episcleral plaque placement would involve destroying the patient's filtering site and that epiconjunctival placement could spare her bleb. Our patient requested eye-and vision-sparing ophthalmic plaque radiation therapy. Our clinical practice and this report conformed to both the tenets of the Declaration of Helsinki and the US Health Insurance Portability and Accountability Act.
Surgery
Intraoperatively, we transilluminated the globe to reveal the tumor base. We then measured the tumor and marked the tumor's edge (on the conjunctiva) plus an additional 2 mm margin. Thus, the radioactive plaque had to straddle the limbus to cover the marked target zone (Fig. 2) .
The plaque was affixed to the eye wall over the targeted zone using four 5-0 absorbable sutures. Then we lifted the anterior aspect of the plaque, to slide in an unsutured 10-to 15-mm-wide, 0.1-mm-thick AG-type amniotic membrane (Bio-Tissue) between the gold and the corneal epithelium (to insulate and protect the cornea) (1). Finally, another superthick (2-3 mm), 20 × 25 mm amniotic membrane (Bio-Tissue) was sewn to conjunctiva to create a previously unreported and novel amniotic membrane cover over the back of the plaque (Fig. 2) . This allowed the eyelid to glide over the plaque. The large size of the second amniotic membrane allowed us to avoid suturing the conjunctival bleb. After 1 week, both the radioactive plaque and amniotic membrane grafts were surgically removed. Care was taken to avoid perforating the conjunctiva or harming the filtering bleb.
Radioactive plaque and dosimetry
A 12-mm-diameter gold, palladium-103 ( 103 Pd) eye plaque contained 8 seeds (Theragenics) at 3.11 U/seed, total 19.2 mCi. The prescription point was 2 mm from the inner scleral surface. The plaque was in place for 1 week (total 167.5 hours) for a total dose of 99.1 Gy to the prescription point. Calculated doses (Gy) to normal ocular structures were lens center (27.0), optic disc (2.1), central fovea (2.3), opposite retina (1.8), and inner sclera (188.7), respectively.
Results
Two weeks after plaque explantation surgery, the patient's mild superficial punctate keratopathy resolved. Her bleb appeared functional with an intraocular pressure measurement of 14 mm Hg in the left eye. However, 1.5 years after radiotherapy, she developed a sterile blebitis (successfully treated with topical antibiotic for 1 month). Six months later, she developed a hyphema (2 years after irradiation) that resolved after 1 intravitreal bevacizumab 1.25 mg injection. It is important to note that she also had a sterile blebitis 8 years prior to plaque irradiation, which was also treated with topical antibiotics for 1 month.
Six years after
103
Pd brachytherapy, the patient's visual acuity was 20/30 and her IOP was 12 mmHg OS (on brimonidine tartrate 0.2% [Allergan] and brinzolamide 1% [Alcon Laboratories]), both twice daily in the left eye (Fig. 3) . The ciliary body melanoma size then measured 5.9 × 5.5 mm base × 1.3 mm thick (decreased 35% in thickness). Furthermore, there has been no clinical evidence of eyelash loss, dry eye, keratopathy, iris neovascularization, radiation retinopathy, or optic neuropathy (2) . There has been no evidence of metastatic uveal melanoma.
Discussion
In this case, preservation of the patient's functioning superior cystic conjunctival bleb was an important consideration. Bleb-sparing radioactive plaque surgery required that we use amniotic membranes to protect conjunctival tissue from the radioactive device and to create a novel amniotic membrane flap to cover the plaque.
The 2014 American Brachytherapy Society Consensus Guidelines defined normal plaque placement as when plaque covers the base of the tumor along with a free margin of normal tissue (2). In our case, this was accomplished by plaque placement over markings on the conjunctiva and cornea (3). As corneal plaque placement is typically painful, the patient's pain was buffered by placement of a subjacent amniotic membrane beneath the plaque (1, 3) . Amniotic membranes are human tissue and 0.1 mm thick -this did not appreciably affect the tumor dose. This same tissue may have helped protect the filtering bleb from the effects of radiation. In contrast, the flexible plastics (e.g., silicone) used to create contact lenses have been shown to attenuate radiation (4) .
Comparative dosimetry studies have shown that the use of 103 Pd (versus 125 I) slightly increases the radiation dose to the conjunctiva and sclera within the targeted zone, while significantly decreasing irradiation to the macula, optic nerve, and globe (5). In contrast, the use of 103 Pd) markedly increases the dose to the conjunctival bleb and sclera within the targeted zone (6, 7) . Therefore, eye cancer specialists using alternative brachytherapy techniques (particularly the beta-emitting 106 Ru) through a filtering bleb may observe different outcomes.
While our patient had minor plaque-related short-term keratopathy and a late blebitis and eventually required additional topical glaucoma medications, she did not require further glaucoma surgery, nor did she develop sight-limiting radiation retinopathy. Though it is possible, we will never know if her single episode of blebitis was related to the radiation. However, it resolved with topical antibiotics and she functioned well for 18 months prior.
Conclusions
Radioactive plaque therapy has largely replaced iridocyclectomy in the treatment of ciliary body melanoma (8, 9) . Plaques have several benefits over more invasive surgery: they preserve maximal iris structure and function, and avoid the (albeit minimal) risks of acute surgery-related hyphema, endophthalmitis, traumatic cataract, and retinal detachment (9) . Although the long-term risk of radiation-induced cataract is high, there are no reported radiation-related impediments to their surgical rehabilitation (10).
Herein we have described how
103
Pd plaque radiation therapy was used through a functioning filtering bleb in treatment of an underlying ciliary body melanoma with extrascleral extension. In this case, our technique offered a patient extended life for her trabeculectomy site and excellent local tumor control.
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